Skip to main content
Concurrent MYC overexpression and TP53/p53 alterations indicative of poor prognosis in MCL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Concurrent MYC overexpression and TP53/p53 alterations indicative of poor prognosis in MCL
User login
Username
Password
Reset your password
Concept
Lead
score
Mantle Cell Lymphoma
1
0.94
Tumor Genetics
0
0.85
Tumor
0
0.8
Prognosis
0
0.85
Lymphoma
0
0.34
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
0.94
Edit Tags